elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37360025-0879DC09-37F2-4A6C-AD85-AFC3422F5192
Q37360025-0879DC09-37F2-4A6C-AD85-AFC3422F5192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360025-0879DC09-37F2-4A6C-AD85-AFC3422F5192
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
P2860
Q37360025-0879DC09-37F2-4A6C-AD85-AFC3422F5192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360025-0879DC09-37F2-4A6C-AD85-AFC3422F5192
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a1d192bd2d0fb53ea5a2650b8ce56bf4f611954
P2860
Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.